Advances and critical concerns with the microfluidic enrichments of circulating tumor cells

Over the past two decades, circulating tumor cells (CTCs) have been widely recognized for their importance in clinical trials. While most enrichment methods for these cells have been conducted through the batch process due to their rarity in blood and the need for large sample volumes, the batch pro...

Full description

Saved in:
Bibliographic Details
Published inLab on a chip Vol. 14; no. 1; pp. 45 - 56
Main Authors Hyun, Kyung-A, Jung, Hyo-Il
Format Journal Article
LanguageEnglish
Published England 07.01.2014
Subjects
Antibodies - chemistry
Antibodies - immunology
Antineoplastic Agents - therapeutic use
Biomarkers, Tumor - blood
Biomarkers, Tumor - metabolism
Cell Adhesion Molecules - immunology
Cell Adhesion Molecules - metabolism
Cell Separation - instrumentation
Cell Separation - methods
Humans
Immunomagnetic Separation - methods
Microfluidic Analytical Techniques - instrumentation
Microfluidic Analytical Techniques - methods
Neoplasms - diagnosis
Neoplasms - drug therapy
Neoplastic Cells, Circulating - metabolism
Online AccessGet full text
ISSN1473-0197
1473-0189
1473-0189
DOI10.1039/c3lc50582k

Cover

Abstract Over the past two decades, circulating tumor cells (CTCs) have been widely recognized for their importance in clinical trials. While most enrichment methods for these cells have been conducted through the batch process due to their rarity in blood and the need for large sample volumes, the batch process leads to unavoidable cell loss. Given the heterogenetic features of CTCs, this cell loss may limit the validity of research that relies on the isolation of CTCs; such research includes cancer prognosis, diagnosis of minimal residual diseases, assessment of tumor sensitivity to anticancer drugs, and the personalization of anticancer therapies. Recent advances in microfluidic approaches have made it possible to enrich CTCs with a small degree of cell loss. In this review, we highlight several microfluidic-based positive and negative enrichment methods that are the subject of considerable research interest ( e.g. EpCAM-dependent assay and EpCAM-independent assay) and suggest a microfluidic-based single cell analysis platform for the down-stream analysis of CTCs. We also discuss critical concerns and future directions for research. Over the past two decades, circulating tumor cells (CTCs) have been widely recognized for their importance in clinical trials.
AbstractList Over the past two decades, circulating tumor cells (CTCs) have been widely recognized for their importance in clinical trials. While most enrichment methods for these cells have been conducted through the batch process due to their rarity in blood and the need for large sample volumes, the batch process leads to unavoidable cell loss. Given the heterogenetic features of CTCs, this cell loss may limit the validity of research that relies on the isolation of CTCs; such research includes cancer prognosis, diagnosis of minimal residual diseases, assessment of tumor sensitivity to anticancer drugs, and the personalization of anticancer therapies. Recent advances in microfluidic approaches have made it possible to enrich CTCs with a small degree of cell loss. In this review, we highlight several microfluidic-based positive and negative enrichment methods that are the subject of considerable research interest ( e.g. EpCAM-dependent assay and EpCAM-independent assay) and suggest a microfluidic-based single cell analysis platform for the down-stream analysis of CTCs. We also discuss critical concerns and future directions for research. Over the past two decades, circulating tumor cells (CTCs) have been widely recognized for their importance in clinical trials.
Over the past two decades, circulating tumor cells (CTCs) have been widely recognized for their importance in clinical trials. While most enrichment methods for these cells have been conducted through the batch process due to their rarity in blood and the need for large sample volumes, the batch process leads to unavoidable cell loss. Given the heterogenetic features of CTCs, this cell loss may limit the validity of research that relies on the isolation of CTCs; such research includes cancer prognosis, diagnosis of minimal residual diseases, assessment of tumor sensitivity to anticancer drugs, and the personalization of anticancer therapies. Recent advances in microfluidic approaches have made it possible to enrich CTCs with a small degree of cell loss. In this review, we highlight several microfluidic-based positive and negative enrichment methods that are the subject of considerable research interest (e.g. EpCAM-dependent assay and EpCAM-independent assay) and suggest a microfluidic-based single cell analysis platform for the down-stream analysis of CTCs. We also discuss critical concerns and future directions for research.Over the past two decades, circulating tumor cells (CTCs) have been widely recognized for their importance in clinical trials. While most enrichment methods for these cells have been conducted through the batch process due to their rarity in blood and the need for large sample volumes, the batch process leads to unavoidable cell loss. Given the heterogenetic features of CTCs, this cell loss may limit the validity of research that relies on the isolation of CTCs; such research includes cancer prognosis, diagnosis of minimal residual diseases, assessment of tumor sensitivity to anticancer drugs, and the personalization of anticancer therapies. Recent advances in microfluidic approaches have made it possible to enrich CTCs with a small degree of cell loss. In this review, we highlight several microfluidic-based positive and negative enrichment methods that are the subject of considerable research interest (e.g. EpCAM-dependent assay and EpCAM-independent assay) and suggest a microfluidic-based single cell analysis platform for the down-stream analysis of CTCs. We also discuss critical concerns and future directions for research.
Over the past two decades, circulating tumor cells (CTCs) have been widely recognized for their importance in clinical trials. While most enrichment methods for these cells have been conducted through the batch process due to their rarity in blood and the need for large sample volumes, the batch process leads to unavoidable cell loss. Given the heterogenetic features of CTCs, this cell loss may limit the validity of research that relies on the isolation of CTCs; such research includes cancer prognosis, diagnosis of minimal residual diseases, assessment of tumor sensitivity to anticancer drugs, and the personalization of anticancer therapies. Recent advances in microfluidic approaches have made it possible to enrich CTCs with a small degree of cell loss. In this review, we highlight several microfluidic-based positive and negative enrichment methods that are the subject of considerable research interest (e.g. EpCAM-dependent assay and EpCAM-independent assay) and suggest a microfluidic-based single cell analysis platform for the down-stream analysis of CTCs. We also discuss critical concerns and future directions for research.
Author Jung, Hyo-Il
Hyun, Kyung-A
AuthorAffiliation Yonsei University
School of Mechanical Engineering
AuthorAffiliation_xml – sequence: 0
  name: School of Mechanical Engineering
– sequence: 0
  name: Yonsei University
Author_xml – sequence: 1
  givenname: Kyung-A
  surname: Hyun
  fullname: Hyun, Kyung-A
– sequence: 2
  givenname: Hyo-Il
  surname: Jung
  fullname: Jung, Hyo-Il
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23982141$$D View this record in MEDLINE/PubMed
BookMark eNptkctLAzEQxoNUrK1evCs5irCa176OZfGFBS968rBkZxMb3c3WJKv437u1tYJ4mmH4zcc330zQyHZWIXREyTklPL8A3kBM4oy97qB9KlIeEZrlo22fp2M08f6FEBqLJNtDY8bzjFFB99HTrH6XFpTH0tYYnAkGZIOhG2bOevxhwgKHhcKtAdfppje1AaysM7BolQ0edxqDcdA3Mhj7jEPfdg6Dahp_gHa1bLw63NQpery6fChuovn99W0xm0fASR4ixgXkNVGQKJ0QIWMlJEtlnsdEDeZZBSpJE8HiVNeaSFJBJRORZbXWmWBc8ik6XesuXffWKx_K1viVA2lV1_uSioSlCeOcDujJBu2rVtXl0plWus_yJ5ABOFsDw7XeO6W3CCXlKu2y4PPiO-27ASZ_YDBhiKGzwUnT_L9yvF5xHrbSvw_kX2hxjBI
CitedBy_id crossref_primary_10_1002_adma_201903663
crossref_primary_10_1002_elps_202100234
crossref_primary_10_1002_cam4_3077
crossref_primary_10_1016_j_snb_2018_01_135
crossref_primary_10_1002_admi_202300492
crossref_primary_10_1016_j_mne_2019_01_002
crossref_primary_10_1021_acsnano_6b02208
crossref_primary_10_3389_fonc_2021_701298
crossref_primary_10_1186_s13045_019_0735_4
crossref_primary_10_3390_mi9030106
crossref_primary_10_1021_acsami_7b10094
crossref_primary_10_1063_1_4935563
crossref_primary_10_1038_srep06052
crossref_primary_10_1016_j_bios_2016_08_002
crossref_primary_10_1109_TBME_2018_2875361
crossref_primary_10_1039_c6ib00202A
crossref_primary_10_1002_elps_201600386
crossref_primary_10_1016_j_actbio_2015_09_009
crossref_primary_10_1016_j_msec_2018_12_040
crossref_primary_10_1002_viw2_8
crossref_primary_10_3390_mi8110315
crossref_primary_10_1016_j_coche_2016_01_005
crossref_primary_10_1039_D0LC01101K
crossref_primary_10_1016_j_aca_2019_01_054
crossref_primary_10_3390_s17122934
crossref_primary_10_1063_5_0005373
crossref_primary_10_1177_1533034615583762
crossref_primary_10_1002_chem_201800305
crossref_primary_10_1007_s12010_019_03199_4
crossref_primary_10_3390_bios11090312
crossref_primary_10_1002_advs_201500118
crossref_primary_10_1039_C5LC00947B
crossref_primary_10_1016_j_molimm_2017_12_017
crossref_primary_10_1063_1_4930983
crossref_primary_10_1115_1_4030420
crossref_primary_10_1007_s13206_016_0201_0
crossref_primary_10_1021_acsnano_5b00750
crossref_primary_10_1038_s41598_017_00232_6
crossref_primary_10_1038_srep38809
crossref_primary_10_3390_gels8070391
crossref_primary_10_1039_C5AN01762A
crossref_primary_10_3390_cancers13174446
crossref_primary_10_1016_j_chroma_2014_12_037
crossref_primary_10_1080_09205063_2020_1748332
crossref_primary_10_1002_adhm_201700845
crossref_primary_10_1039_C4AN01768D
crossref_primary_10_1021_jacs_6b12236
crossref_primary_10_1371_journal_pone_0189923
crossref_primary_10_1007_s10404_018_2082_0
crossref_primary_10_1016_j_jconrel_2018_02_029
crossref_primary_10_1021_acs_analchem_6b03534
crossref_primary_10_1038_srep15342
crossref_primary_10_18632_oncotarget_8250
crossref_primary_10_1002_elps_201800446
crossref_primary_10_1063_1_5087690
crossref_primary_10_1016_j_giec_2017_06_008
crossref_primary_10_1016_j_bios_2017_10_036
crossref_primary_10_1016_j_talanta_2024_127025
crossref_primary_10_1007_s10404_017_1933_4
crossref_primary_10_1177_107327481502200207
crossref_primary_10_1021_nn5004277
crossref_primary_10_1016_j_chroma_2014_11_027
crossref_primary_10_1002_elps_201900341
crossref_primary_10_1007_s44174_024_00257_2
crossref_primary_10_1007_s13206_017_2105_z
crossref_primary_10_1021_acs_analchem_0c03920
crossref_primary_10_1016_j_addr_2018_01_002
crossref_primary_10_2217_bmm_2020_0022
crossref_primary_10_1002_adfm_201504176
crossref_primary_10_1039_C6LC01527A
crossref_primary_10_1039_C6RA01004K
crossref_primary_10_1039_C7AN01965C
crossref_primary_10_1016_j_bios_2022_114715
crossref_primary_10_1002_adhm_201600009
crossref_primary_10_1039_C4LC01422G
crossref_primary_10_3390_cancers12041011
crossref_primary_10_1002_smll_201403658
crossref_primary_10_1038_s41598_019_44401_1
crossref_primary_10_1016_j_bios_2014_07_019
crossref_primary_10_1063_5_0100079
crossref_primary_10_1021_acs_analchem_6b01130
crossref_primary_10_1016_j_actbio_2020_05_004
crossref_primary_10_3390_mi9070353
crossref_primary_10_1002_elps_201800361
crossref_primary_10_1016_j_bej_2022_108551
crossref_primary_10_1016_j_canlet_2016_02_024
crossref_primary_10_1016_j_snb_2016_05_163
crossref_primary_10_1039_C5AN00464K
crossref_primary_10_1016_j_colsurfb_2018_11_049
crossref_primary_10_3390_mi9040171
Cites_doi 10.1038/nrclinonc.2009.44
10.1002/anie.201208452
10.1186/1471–2407-12–178
10.1063/1.4788914
10.1371/journal.pone.0033788
10.1002/smll.201202317
10.1007/s10544-012-9718-8
10.1063/1.1823015
10.1039/c3lc41256c
10.1016/j.molmed.2010.07.001
10.1039/c0lc00345j
10.1093/annonc/mds336
10.1039/C3LC50617G
10.1038/nature05058
10.1126/science.1228522
10.1016/j.cancergen.2011.10.011
10.1007/s10549-008-0290-0
10.1073/pnas.1012539107
10.1002/elps.201200417
10.1039/c2lc40072c
10.1002/ange.201108695
10.1002/anie.201005853
10.1021/ac101222x
10.1016/j.bios.2012.06.016
10.1038/nrc1886
10.1200/JCO.2010.33.3716
10.1038/nnano.2007.388
10.1039/C0LC00332H
10.1007/s10555-012-9398-0
10.1021/ac3011704
10.1007/s10544-010-9485-3
10.1002/cyto.a.21014
10.1039/c2lc40679a
10.1186/1471-2407-12-178
10.1373/clinchem.2011.176669
10.1007/s10544-007-9085-z
10.1007/s00262-012-1387-1
10.1016/j.ab.2012.07.007
10.1002/adhm.201200046
10.1016/j.bios.2013.03.017
10.1063/1.4808456
10.1038/sj.bjc.6602310
10.1007/s10544-009-9305-9
10.1021/ac301723s
10.1146/annurev-med-050311-163404
10.1002/ijc.28312
10.1016/j.bios.2012.07.021
10.1038/nrc3475
10.1021/ac303284u
10.1021/ac902683t
10.1021/ac3037766
10.1039/c2lc41048f
10.1039/c2lc40356k
10.1039/c2lc40065k
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1039/c3lc50582k
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
Chemistry
Biology
EISSN 1473-0189
EndPage 56
ExternalDocumentID 23982141
10_1039_C3LC50582K
c3lc50582k
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
-JG
0-7
0R~
0VX
29L
4.4
5GY
705
70~
7~J
AAEMU
AAIWI
AAJAE
AAMEH
AANOJ
AAWGC
AAXHV
AAXPP
ABASK
ABDVN
ABEMK
ABJNI
ABPDG
ABRYZ
ABXOH
ACGFS
ACIWK
ACLDK
ADMRA
ADSRN
AEFDR
AENEX
AENGV
AESAV
AETIL
AFLYV
AFOGI
AFVBQ
AGEGJ
AGKEF
AGRSR
AGSTE
AHGCF
ALMA_UNASSIGNED_HOLDINGS
ANBJS
ANUXI
APEMP
ASKNT
AUDPV
BLAPV
BSQNT
C6K
CS3
DU5
EBS
ECGLT
EE0
EF-
EJD
F5P
GGIMP
GNO
H13
HZ~
H~N
IDZ
J3G
J3H
J3I
L-8
M4U
N9A
O9-
R7B
RAOCF
RCNCU
RNS
ROL
RPMJG
RRA
RRC
RSCEA
SKA
SLH
VH6
0UZ
1TJ
53G
71~
AAYXX
ACHDF
ACRPL
ADNMO
AFFNX
AFRZK
AGQPQ
AHGXI
AKMSF
ALSGL
ANLMG
BBWZM
CAG
CITATION
COF
EEHRC
FEDTE
HVGLF
IDY
NDZJH
R56
RCLXC
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c309t-234c9d0ec6ef604a5e4a27a9950e0192bce6764257fdf0a0bcba6488dff8423a3
ISSN 1473-0197
1473-0189
IngestDate Fri Jul 11 02:03:17 EDT 2025
Mon Jul 21 06:05:36 EDT 2025
Tue Jul 01 00:52:34 EDT 2025
Thu Apr 24 23:01:52 EDT 2025
Tue Dec 17 20:59:51 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c309t-234c9d0ec6ef604a5e4a27a9950e0192bce6764257fdf0a0bcba6488dff8423a3
Notes Kyung-A Hyun is a graduate student in the unified masters and doctoral degrees course at the School of Mechanical Engineering, Yonsei University, South Korea. She received her bachelor's degree in Biomedical Engineering in 2011 from Gachon University of Medicine and Science. Her current research area is the separation and characterization of circulating rare cells (CRCs) from blood using microfluidic technology.
Hyo-Il Jung is a professor in the School of Mechanical Engineering, Yonsei University, South Korea, where he leads the Laboratory of Biochip Technology. He obtained BSc and MSc degrees (Biotechnology) from the Korea Advanced Institute of Science and Technology (KAIST) in 1993 and 1995, respectively, and received a PhD degree (Physical Biochemistry) from the University of Cambridge, United Kingdom, in 2001. His current research interests centre on developing microfluidic devices to solve the major technical problems in biomedical sciences.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMID 23982141
PQID 1462762331
PQPubID 23479
PageCount 12
ParticipantIDs pubmed_primary_23982141
crossref_citationtrail_10_1039_C3LC50582K
proquest_miscellaneous_1462762331
crossref_primary_10_1039_C3LC50582K
rsc_primary_c3lc50582k
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-01-07
PublicationDateYYYYMMDD 2014-01-07
PublicationDate_xml – month: 01
  year: 2014
  text: 2014-01-07
  day: 07
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Lab on a chip
PublicationTitleAlternate Lab Chip
PublicationYear 2014
References Whitesides (C3LC50582K-(cit8)/*[position()=1]) 2006; 44
lin (C3LC50582K-(cit21)/*[position()=1]) 2013; 40
Hosokawa (C3LC50582K-(cit25)/*[position()=1]) 2010; 82
Kim (C3LC50582K-(cit20)/*[position()=1]) 2012; 12
Burgess (C3LC50582K-(cit38)/*[position()=1]) 2013
Hou (C3LC50582K-(cit48)/*[position()=1]) 2013; 52
Gorges (C3LC50582K-(cit37)/*[position()=1]) 2013
Moon (C3LC50582K-(cit29)/*[position()=1]) 2013; 7
Park (C3LC50582K-(cit22)/*[position()=1]) 2012; 84
Kang (C3LC50582K-(cit15)/*[position()=1]) 2012; 12
Yu (C3LC50582K-(cit39)/*[position()=1]) 2013; 339
Liu (C3LC50582K-(cit50)/*[position()=1]) 2013; 47
Stott (C3LC50582K-(cit10)/*[position()=1]) 2010; 107
Hou (C3LC50582K-(cit5)/*[position()=1]) 2012; 30
Moon (C3LC50582K-(cit31)/*[position()=1]) 2011; 11
Chen (C3LC50582K-(cit18)/*[position()=1]) 2012; 429
Tan (C3LC50582K-(cit41)/*[position()=1]) 2009; 1
Cross (C3LC50582K-(cit42)/*[position()=1]) 2007; 2
Kim (C3LC50582K-(cit23)/*[position()=1]) 2013
Powell (C3LC50582K-(cit45)/*[position()=1]) 2012; 7
Schiro (C3LC50582K-(cit52)/*[position()=1]) 2012; 124
Aggarwal (C3LC50582K-(cit3)/*[position()=1]) 2013; 24
Zheng (C3LC50582K-(cit26)/*[position()=1]) 2011; 13
Huang (C3LC50582K-(cit55)/*[position()=1]) 2013; 13
Augustsson (C3LC50582K-(cit56)/*[position()=1]) 2012; 84
Bidard (C3LC50582K-(cit6)/*[position()=1]) 2012
Pantel (C3LC50582K-(cit2)/*[position()=1]) 2010; 16
Warkiani (C3LC50582K-(cit53)/*[position()=1]) 2013
Mehlen (C3LC50582K-(cit1)/*[position()=1]) 2006; 6
Gorges (C3LC50582K-(cit36)/*[position()=1]) 2012
Zhu (C3LC50582K-(cit9)/*[position()=1]) 2007; 9
Kim (C3LC50582K-(cit17)/*[position()=1]) 2013; 85
Yao (C3LC50582K-(cit57)/*[position()=1]) 2013
Hyun (C3LC50582K-(cit49)/*[position()=1]) 2013; 34
Lv (C3LC50582K-(cit54)/*[position()=1]) 2013; 7
Wang (C3LC50582K-(cit11)/*[position()=1]) 2011; 50
Hyun (C3LC50582K-(cit32)/*[position()=1]) 2013; 85
Mayer (C3LC50582K-(cit47)/*[position()=1]) 2011; 204
Sieuwerts (C3LC50582K-(cit43)/*[position()=1]) 2009; 118
Chung (C3LC50582K-(cit46)/*[position()=1]) 2012; 1
Prang (C3LC50582K-(cit24)/*[position()=1]) 2005; 92
Sun (C3LC50582K-(cit27)/*[position()=1]) 2012; 12
Mikolajczyk (C3LC50582K-(cit40)/*[position()=1]) 2011
Balic (C3LC50582K-(cit4)/*[position()=1]) 2013; 64
Hyun (C3LC50582K-(cit30)/*[position()=1]) 2013; 40
Gorges (C3LC50582K-(cit35)/*[position()=1]) 2012
Huang (C3LC50582K-(cit16)/*[position()=1]) 2012
Inglis (C3LC50582K-(cit19)/*[position()=1]) 2004; 85
Kralj (C3LC50582K-(cit13)/*[position()=1]) 2012; 12
Takao (C3LC50582K-(cit14)/*[position()=1]) 2011; 79A
Hou (C3LC50582K-(cit28)/*[position()=1]) 2013; 3
Thomas (C3LC50582K-(cit34)/*[position()=1]) 2012; 12
Ozkumur (C3LC50582K-(cit51)/*[position()=1]) 2013; 4
Chen (C3LC50582K-(cit33)/*[position()=1]) 2011; 11
Pantel (C3LC50582K-(cit7)/*[position()=1]) 2009; 6
Zeng (C3LC50582K-(cit44)/*[position()=1]) 2010; 82
Hughes (C3LC50582K-(cit12)/*[position()=1]) 2012; 58
References_xml – volume: 6
  start-page: 339
  year: 2009
  ident: C3LC50582K-(cit7)/*[position()=1]
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/nrclinonc.2009.44
– volume: 52
  start-page: 3379
  year: 2013
  ident: C3LC50582K-(cit48)/*[position()=1]
  publication-title: Angew. Chem., Int. Ed.
  doi: 10.1002/anie.201208452
– year: 2012
  ident: C3LC50582K-(cit36)/*[position()=1]
  publication-title: BMC Cancer
  doi: 10.1186/1471–2407-12–178
– volume: 7
  start-page: 014105
  year: 2013
  ident: C3LC50582K-(cit29)/*[position()=1]
  publication-title: Biomicrofluidics
  doi: 10.1063/1.4788914
– volume: 7
  start-page: e33788
  year: 2012
  ident: C3LC50582K-(cit45)/*[position()=1]
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0033788
– year: 2013
  ident: C3LC50582K-(cit23)/*[position()=1]
  publication-title: Small
  doi: 10.1002/smll.201202317
– year: 2012
  ident: C3LC50582K-(cit16)/*[position()=1]
  publication-title: Biomed. Microdevices
  doi: 10.1007/s10544-012-9718-8
– volume: 85
  start-page: 5093
  year: 2004
  ident: C3LC50582K-(cit19)/*[position()=1]
  publication-title: Appl. Phys. Lett.
  doi: 10.1063/1.1823015
– volume: 13
  start-page: 1371
  year: 2013
  ident: C3LC50582K-(cit55)/*[position()=1]
  publication-title: Lab Chip
  doi: 10.1039/c3lc41256c
– volume: 16
  start-page: 398
  year: 2010
  ident: C3LC50582K-(cit2)/*[position()=1]
  publication-title: Trends Mol. Med.
  doi: 10.1016/j.molmed.2010.07.001
– volume: 11
  start-page: 1118
  year: 2011
  ident: C3LC50582K-(cit31)/*[position()=1]
  publication-title: Lab Chip
  doi: 10.1039/c0lc00345j
– volume: 24
  start-page: 420
  year: 2013
  ident: C3LC50582K-(cit3)/*[position()=1]
  publication-title: Ann. Oncol.
  doi: 10.1093/annonc/mds336
– year: 2013
  ident: C3LC50582K-(cit53)/*[position()=1]
  publication-title: Lab Chip
  doi: 10.1039/C3LC50617G
– volume: 44
  start-page: 368
  year: 2006
  ident: C3LC50582K-(cit8)/*[position()=1]
  publication-title: Nature
  doi: 10.1038/nature05058
– volume: 339
  start-page: 580
  year: 2013
  ident: C3LC50582K-(cit39)/*[position()=1]
  publication-title: Science
  doi: 10.1126/science.1228522
– volume: 204
  start-page: 589
  year: 2011
  ident: C3LC50582K-(cit47)/*[position()=1]
  publication-title: Cancer Genet.
  doi: 10.1016/j.cancergen.2011.10.011
– volume: 118
  start-page: 455
  year: 2009
  ident: C3LC50582K-(cit43)/*[position()=1]
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-008-0290-0
– volume: 107
  start-page: 18392
  year: 2010
  ident: C3LC50582K-(cit10)/*[position()=1]
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1012539107
– volume: 3
  start-page: 1
  year: 2013
  ident: C3LC50582K-(cit28)/*[position()=1]
  publication-title: Sci. Rep.
– volume: 34
  start-page: 1028
  year: 2013
  ident: C3LC50582K-(cit49)/*[position()=1]
  publication-title: Electrophoresis
  doi: 10.1002/elps.201200417
– volume: 12
  start-page: 2175
  year: 2012
  ident: C3LC50582K-(cit15)/*[position()=1]
  publication-title: Lab Chip
  doi: 10.1039/c2lc40072c
– volume: 124
  start-page: 4696
  year: 2012
  ident: C3LC50582K-(cit52)/*[position()=1]
  publication-title: Angew. Chem.
  doi: 10.1002/ange.201108695
– volume: 50
  start-page: 3084
  year: 2011
  ident: C3LC50582K-(cit11)/*[position()=1]
  publication-title: Angew. Chem., Int. Ed.
  doi: 10.1002/anie.201005853
– volume: 82
  start-page: 6629
  year: 2010
  ident: C3LC50582K-(cit25)/*[position()=1]
  publication-title: Anal. Chem.
  doi: 10.1021/ac101222x
– volume: 40
  start-page: 63
  year: 2013
  ident: C3LC50582K-(cit21)/*[position()=1]
  publication-title: Biosens. Bioelectron.
  doi: 10.1016/j.bios.2012.06.016
– volume: 6
  start-page: 449
  year: 2006
  ident: C3LC50582K-(cit1)/*[position()=1]
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1886
– volume: 30
  start-page: 525
  year: 2012
  ident: C3LC50582K-(cit5)/*[position()=1]
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2010.33.3716
– volume: 2
  start-page: 780
  year: 2007
  ident: C3LC50582K-(cit42)/*[position()=1]
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/nnano.2007.388
– volume: 11
  start-page: 474
  year: 2011
  ident: C3LC50582K-(cit33)/*[position()=1]
  publication-title: Lab Chip
  doi: 10.1039/C0LC00332H
– year: 2012
  ident: C3LC50582K-(cit6)/*[position()=1]
  publication-title: Cancer Metastasis Rev.
  doi: 10.1007/s10555-012-9398-0
– volume: 4
  start-page: 179ra47
  year: 2013
  ident: C3LC50582K-(cit51)/*[position()=1]
  publication-title: Sci. Transl. Med.
– volume: 84
  start-page: 7400
  year: 2012
  ident: C3LC50582K-(cit22)/*[position()=1]
  publication-title: Anal. Chem.
  doi: 10.1021/ac3011704
– volume: 13
  start-page: 203
  year: 2011
  ident: C3LC50582K-(cit26)/*[position()=1]
  publication-title: Biomed. Microdevices
  doi: 10.1007/s10544-010-9485-3
– volume: 79A
  start-page: 107
  year: 2011
  ident: C3LC50582K-(cit14)/*[position()=1]
  publication-title: Cytometry, Part A
  doi: 10.1002/cyto.a.21014
– volume: 12
  start-page: 3952
  year: 2012
  ident: C3LC50582K-(cit27)/*[position()=1]
  publication-title: Lab Chip
  doi: 10.1039/c2lc40679a
– year: 2012
  ident: C3LC50582K-(cit35)/*[position()=1]
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-12-178
– volume: 58
  start-page: 846
  year: 2012
  ident: C3LC50582K-(cit12)/*[position()=1]
  publication-title: Clin. Chem.
  doi: 10.1373/clinchem.2011.176669
– volume: 9
  start-page: 745
  year: 2007
  ident: C3LC50582K-(cit9)/*[position()=1]
  publication-title: Biomed. Microdevices
  doi: 10.1007/s10544-007-9085-z
– start-page: 252361
  year: 2011
  ident: C3LC50582K-(cit40)/*[position()=1]
  publication-title: J. Oncol.
– year: 2013
  ident: C3LC50582K-(cit37)/*[position()=1]
  publication-title: Cancer Immunol. Immunother.
  doi: 10.1007/s00262-012-1387-1
– volume: 429
  start-page: 116
  year: 2012
  ident: C3LC50582K-(cit18)/*[position()=1]
  publication-title: Anal. Biochem.
  doi: 10.1016/j.ab.2012.07.007
– volume: 1
  start-page: 432
  year: 2012
  ident: C3LC50582K-(cit46)/*[position()=1]
  publication-title: Adv. Healthcare Mater.
  doi: 10.1002/adhm.201200046
– volume: 47
  start-page: 113
  year: 2013
  ident: C3LC50582K-(cit50)/*[position()=1]
  publication-title: Biosens. Bioelectron.
  doi: 10.1016/j.bios.2013.03.017
– volume: 7
  start-page: 034109
  year: 2013
  ident: C3LC50582K-(cit54)/*[position()=1]
  publication-title: Biomicrofluidics
  doi: 10.1063/1.4808456
– volume: 92
  start-page: 342
  year: 2005
  ident: C3LC50582K-(cit24)/*[position()=1]
  publication-title: Brit. J. Cancer
  doi: 10.1038/sj.bjc.6602310
– volume: 1
  start-page: 883
  year: 2009
  ident: C3LC50582K-(cit41)/*[position()=1]
  publication-title: Biomed. Microdevices
  doi: 10.1007/s10544-009-9305-9
– volume: 84
  start-page: 7954
  year: 2012
  ident: C3LC50582K-(cit56)/*[position()=1]
  publication-title: Anal. Chem.
  doi: 10.1021/ac301723s
– volume: 64
  start-page: 31
  year: 2013
  ident: C3LC50582K-(cit4)/*[position()=1]
  publication-title: Annu. Rev. Med.
  doi: 10.1146/annurev-med-050311-163404
– year: 2013
  ident: C3LC50582K-(cit57)/*[position()=1]
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.28312
– volume: 40
  start-page: 206
  year: 2013
  ident: C3LC50582K-(cit30)/*[position()=1]
  publication-title: Biosens. Bioelectron.
  doi: 10.1016/j.bios.2012.07.021
– year: 2013
  ident: C3LC50582K-(cit38)/*[position()=1]
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3475
– volume: 85
  start-page: 2779
  year: 2013
  ident: C3LC50582K-(cit17)/*[position()=1]
  publication-title: Anal. Chem.
  doi: 10.1021/ac303284u
– volume: 82
  start-page: 3183
  year: 2010
  ident: C3LC50582K-(cit44)/*[position()=1]
  publication-title: Anal. Chem.
  doi: 10.1021/ac902683t
– volume: 85
  start-page: 4439
  year: 2013
  ident: C3LC50582K-(cit32)/*[position()=1]
  publication-title: Anal. Chem.
  doi: 10.1021/ac3037766
– volume: 12
  start-page: 4972
  year: 2012
  ident: C3LC50582K-(cit13)/*[position()=1]
  publication-title: Lab Chip
  doi: 10.1039/c2lc41048f
– volume: 12
  start-page: 2634
  year: 2012
  ident: C3LC50582K-(cit34)/*[position()=1]
  publication-title: Lab Chip
  doi: 10.1039/c2lc40356k
– volume: 12
  start-page: 2874
  year: 2012
  ident: C3LC50582K-(cit20)/*[position()=1]
  publication-title: Lab Chip
  doi: 10.1039/c2lc40065k
SSID ssj0015468
Score 2.438199
SecondaryResourceType review_article
Snippet Over the past two decades, circulating tumor cells (CTCs) have been widely recognized for their importance in clinical trials. While most enrichment methods...
SourceID proquest
pubmed
crossref
rsc
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 45
SubjectTerms Antibodies - chemistry
Antibodies - immunology
Antineoplastic Agents - therapeutic use
Biomarkers, Tumor - blood
Biomarkers, Tumor - metabolism
Cell Adhesion Molecules - immunology
Cell Adhesion Molecules - metabolism
Cell Separation - instrumentation
Cell Separation - methods
Humans
Immunomagnetic Separation - methods
Microfluidic Analytical Techniques - instrumentation
Microfluidic Analytical Techniques - methods
Neoplasms - diagnosis
Neoplasms - drug therapy
Neoplastic Cells, Circulating - metabolism
Title Advances and critical concerns with the microfluidic enrichments of circulating tumor cells
URI https://www.ncbi.nlm.nih.gov/pubmed/23982141
https://www.proquest.com/docview/1462762331
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3Pb9MwFMct6ISAA4LCoPySEVzQlJHYzq9jVXXqtjAuqVSJQ-Q4DlR0yZQ1h_LX8xzHSVB7GFzSykmtxB_35esf7z2EPkkwizTzcouJEAYolDEr5TSzRBqIjBDppFINFL9eeYslu1i5qz43X-Ndsk1Pxe-DfiX_QxXKgKvykv0Hsl2lUADfgS8cgTAc78R4qhfwdZhlYZIWCOWJWBWt35oSltdq112-qdfZWpxAZWvxU3u2qT3l60o0KbyU21R9XVYnai7_dihaI56qNQWuPL9vun6wqxuDdQmfP6yuH1y0xmOxK63zzXBOwWHNnII_MIPMV7usdHKfU3mgzNhOttdHtCHUMSL37LNNVXhTQTcClFdAfvVvIbPyfvUtOVtGURLPV_F9dERA_ZMROprO4_OoWx5ymfZxNLdk4s7S8Etf999KY2_4AGKiMkleGjERP0VP2lEAnmqkz9A9WYzRA50XdDdGD2cmDd8YPR5EjHyOvhvkGJBjgxwb5Fghx4AcD5HjAXJc5niAHDfIcYP8BVqezePZwmrzY1iC2uHWIhT-YJkthSdzz2bclYwTn4eha0ul3FMhPd9TRjnPcpvbqUi5BwY7y_MAVDSnx2hUlIV8hTCIVO4wmcksDRj8jNPA5WFu25y4TPjeBH02bZmINni8ymGySZpNDDRMZjSaNe1-OUEfu2tvdMiUg1d9MEgSaFH1nLyQZX2rBqMEXtGUOhP0UrPq6lHRKonD4MwxwOuKe-iv71DtG_So7_Rv0Whb1fIdSMtt-r7taH8A1AZ7Xg
linkProvider Royal Society of Chemistry
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Advances+and+critical+concerns+with+the+microfluidic+enrichments+of+circulating+tumor+cells&rft.jtitle=Lab+on+a+chip&rft.au=Hyun%2C+Kyung-A&rft.au=Jung%2C+Hyo-Il&rft.date=2014-01-07&rft.issn=1473-0189&rft.eissn=1473-0189&rft.volume=14&rft.issue=1&rft.spage=45&rft_id=info:doi/10.1039%2Fc3lc50582k&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1473-0197&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1473-0197&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1473-0197&client=summon